Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis.
Remo PanaccioneEric B CollinsGil Y MelmedSeverine VermeireSilvio DanesePeter D R HigginsChristina S KwonWen ZhouDapo IloDolly SharmaYuri Sanchez GonzalezSi-Tien WangPublished in: Crohn's & colitis 360 (2023)
Upadacitinib may be the most efficacious therapy for moderately to severely active UC based on ITT analyses, with similar safety across advanced therapies.